Implications of spillover effects within the family for medical cost-effectiveness analysis
- PMID: 15960995
- DOI: 10.1016/j.jhealeco.2004.12.002
Implications of spillover effects within the family for medical cost-effectiveness analysis
Abstract
Medical cost-effectiveness analyses traditionally treat patients as isolated individuals and neglect the effects of improvement in patients' health on the welfare of their family members. We use a model based on a family utility function with altruistic linkages to show that there can be direct and indirect effects on the welfare of all family members. We focus specially on a model of how the spillover effects to the spouse in a two-person family might affect choice of treatments for prostate cancer. We then test the predictions of this model by analyzing treatment choices of prostate cancer patients using the linked SEER-Medicare database. We find that our results are consistent with the model's predictions. We conclude that cost-effectiveness analyses may better reflect the full costs and benefits of medical interventions if they incorporate these family effects. However, concerns about equity present a dilemma for the practice of CEA from the societal perspective.
Similar articles
-
A time tradeoff method for eliciting partner's quality of life due to patient's health states in prostate cancer.Med Decis Making. 2010 May-Jun;30(3):355-65. doi: 10.1177/0272989X09349959. Epub 2010 Mar 12. Med Decis Making. 2010. PMID: 20228288
-
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.Am J Med. 2005 Aug;118(8):850-7. doi: 10.1016/j.amjmed.2005.03.001. Am J Med. 2005. PMID: 16084177
-
The costs and benefits of enhanced depression care to employers.Arch Gen Psychiatry. 2006 Dec;63(12):1345-53. doi: 10.1001/archpsyc.63.12.1345. Arch Gen Psychiatry. 2006. PMID: 17146009
-
The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Clin Ther. 2008. PMID: 18343273 Review.
-
Assessing the costs, benefits, cost-benefit ratio, and cost-effectiveness of marital and family treatments: why we should and how we can.J Fam Psychol. 2005 Mar;19(1):28-39. doi: 10.1037/0893-3200.19.1.28. J Fam Psychol. 2005. PMID: 15796650 Review.
Cited by
-
Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment.J Manag Care Spec Pharm. 2024 Sep;30(9):1013-1024. doi: 10.18553/jmcp.2024.30.9.1013. J Manag Care Spec Pharm. 2024. PMID: 39213143 Free PMC article.
-
Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.Addiction. 2016 Apr;111(4):675-84. doi: 10.1111/add.13219. Epub 2015 Dec 17. Addiction. 2016. PMID: 26498740 Free PMC article.
-
The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.Curr Rheumatol Rep. 2015 May;17(5):31. doi: 10.1007/s11926-015-0508-1. Curr Rheumatol Rep. 2015. PMID: 25874347
-
Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.Pharmacoeconomics. 2007;25(9):713-26. doi: 10.2165/00019053-200725090-00001. Pharmacoeconomics. 2007. PMID: 17803331 Review.
-
Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies.Qual Life Res. 2012 Jun;21(5):849-61. doi: 10.1007/s11136-011-9991-7. Epub 2011 Aug 20. Qual Life Res. 2012. PMID: 21858419 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical